Text Size
- News Releases
- What's New
- 11 Jun
- Chugai Files New Drug Application in Japan for Faricimab, the First Bispecific Antibody in Ophthalmology for Diabetic Macular Edema and Neovascular Age-related Macular Degeneration
- 08 Jun
- Chugai Selected as Digital Transformation Stock (DX Stock) 2021
- 31 May
- Chugai Introduces First Cryo-electron Microscopy System in Pharmaceutical Industry in Japan
- 20 May
- Chugai Obtains Approval for FoundationOne Liquid CDx Cancer Genomic Profile to be used as a Companion Diagnostic for Olaparib in BRCA-Mutated Prostate Cancer
- 19 May
- Chugai Launches Polivy Intravenous Infusion for the Treatment of Diffuse Large B-cell Lymphoma
Video Introduction of CHUGAI- Share this site
